N/A
Completed N=201
Social Forces to Improve Statin Adherence (Study B)
Medication Adherence · High Blood Pressure · Diabetes
Source: ClinicalTrials.gov NCT02148523 ↗
Enrolled (actual)
201
Serious AEs
0.0%
Results posted
May 2017
Primary outcomePrimary: Statin Adherence — 79; 84; 80 percentage of correct statin doses
Summary
To assess the effectiveness of social comparison in improving the outcome of statin adherence versus usual care as measured by an electronic pill bottle.
Subjects receiving weekly reports with their adherence and information about their place in the distribution of their peers will have the highest statin adherence of any arm, as measured by electronic pill bottle.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Statin Adherence |
79; 84; 80 | — |
| SECONDARY Morisky Medication Adherence Scale (MMAS) |
6; 6; 5.5 | — |
Eligibility Criteria
Inclusion Criteria
- The subject is Humana insured
- The subject is an English speaking adult
- Age range ≥18 years
- The subject has diagnosis with diabetes for ≥12 months
- The subject has an MPR <70% to a statin medication
- Subjects denies side-effects to their statin medication
Exclusion Criteria
- The subject is <18 years old
- The subject is considered part of a vulnerable population (is a prisoner, a cognitively impaired person, or a pregnant woman)
- On statin combination medication
- The subject does not identify an individual who agrees to serve as their MAP
- The subject reports a clinically important side effect to the statin medication or active liver disease
Data sourced from ClinicalTrials.gov (NCT02148523). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.